Data for: A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Raw data for figures in manuscript
应用场景：
创建时间：
2021-04-26
相关数据集
Towards Eradication of HIV-1: Therapeutic Vaccination with the Peptide-Based Candidate Vacc-4x, 2014
Human immunodeficiency virus (HIV)-1 infection continues to threaten global health with approximately 34 million adults and children living with HIV infection worldwide in 2010. Antiretroviral therapy
CESSDA2020-08-28 更新90
HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects
Little is known about the humoral immune response against DNA prime-recombinant adenovirus 5 (rAd5) boost HIV vaccine among HIV-infected patients on long-term suppressive antiretroviral therapy (ART).
NIAID Data Ecosystem50
T-Helper-Cell Proliferative Responses to Whole-Killed Human Immunodeficiency Virus Type 1 (HIV-1) and p24 Antigens of Different Clades in HIV-1-Infected Subjects Vaccinated with HIV-1 Immunogen (Remune)
The discovery of multiple subtypes of human immunodeficiency virus type 1 (HIV-1) worldwide has created new challenges for the development of both therapeutic and preventive AIDS vaccines. We examined
PubMed Central40
DataSheet_1_Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection.docx
This study aimed to determine the specific cytokine profile in peripheral blood during the early onset of COVID-19 infection. This was a cross-sectional exploratory, single center study. A total of 55
NIAID Data Ecosystem60
Methylation profiles predict ATI outcome in the kick-and-kill therapeutic vaccine BCN02 clinical trial [450K]. Methylation profiles predict ATI outcome in the kick-and-kill therapeutic vaccine BCN02 clinical trial [450K]
BCN02 was an exploratory, single arm study designed to evaluate a kick-and-kill therapeutic vaccine strategy in early-treated HIV infected individuals. The participants in the study received a MVA.HIV
NIAID Data Ecosystem40
